Moleculin Biotech Inc

NASDAQ:MBRX  
3.09
+0.14 (+4.75%)
Earnings Announcements

Moleculin Biotech Reports Quarterly Loss Per Share Of $0.15

Published: 08/12/2021 12:45 GMT
Moleculin Biotech Inc (MBRX) - Moleculin Biotech Inc - Qtrly Loss per Share $0.15.
Moleculin Biotech Inc - Ended Quarter With About $79.5 Million of Cash.
Moleculin Biotech Inc - Believes Current Cash is Sufficient to Meet Its Projected Operating Requirements Into 2024.
Further Company Coverage: Mbrxo ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.21

More details on our Analysts Page.